Sponsored Links
| FDA Grants Fast Track Designation To Tioga Pharmaceuticals' Asimadoline For The Treatment Of Diarrhea-Predominant Irritable Bowel Syndrome |
 |
 |
 |
| Medical News - Irritable-Bowel Syndrome | |||
|
Tioga Pharmaceuticals, Inc. announced that its investigational compound asimadoline has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with diarrhea-predominant irritable bowel syndrome (D-IBS)... Read more: Irritable-Bowel Syndrome News From Medical News Today
|